DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹102,822.5 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| MANKIND PHARMA | ₹93,967.8 Cr | -5.2% | 1.2% | -4.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.1% |
7.6% |
-3.5% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses